ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 90 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2020. The put-call ratio across all filers is 0.71 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,786 | -34.5% | 11,556 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $132,479 | +17.8% | 11,755 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $112,495 | -38.1% | 11,755 | +9.4% | 0.00% | 0.0% |
| Q1 2022 | $181,591 | +24.6% | 10,745 | +58.5% | 0.00% | 0.0% |
| Q4 2021 | $145,702 | -70.9% | 6,780 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $500,771 | +0.2% | 6,780 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $499,957 | +32.7% | 6,780 | +55.1% | 0.01% | +25.0% |
| Q4 2020 | $376,780 | +128.4% | 4,371 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $164,962 | – | 4,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |